✦ LIBER ✦

Statistical considerations in evaluating pharmacogenomics-based clinical effect for confirmatory trials

✍ Scribed by Wang, S.-J.; O'Neill, R. T.; Hung, H. J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Criteria for evaluating background suppr

✍ R.B. Galloway 📂 Article 📅 1967 🏛 Elsevier Science ⚖ 221 KB

A New Statistical Method for Dose-Findin

✍ Peter F. Thall; Elihu H. Estey; Hsi-Guang Sung 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 115 KB

Implications of process evaluation for c

✍ Jacques J.X.R. Geraets; Mariëlle E.J.B. Goossens; Jolanda C.M. van Haastregt; Im 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 137 KB 👁 1 views

Evaluating the effectiveness of using PR

✍ Peter M. Fayers 📂 Article 📅 2008 🏛 Springer Netherlands 🌐 English ⚖ 146 KB

Multicenter clinical trial for evaluatin

✍ G. Fontanesi; F. Giancecchi; R. Rotini; I. Tartaglia; A. Dal Monte; G. Poli; E. 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 360 KB

Cluster randomized clinical trial (ISRCT

✍ Selma R. Tsuji; Alvaro N. Atallah; Fernando C. Aranha; Antonio P. Tonhom; Antoni 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB